American Century Companies Inc. Buys 16,170 Shares of RELX PLC $RELX

Key Points

• American Century Companies Inc. increased its holdings in RELX PLC by 4.0% in the first quarter, now owning 421,270 shares valued at approximately $21.24 million.
• Wall Street analysts have upgraded RELX from a "hold" to a "buy" rating, with one analyst rating it as a Strong Buy and an average rating of "Buy".
• RELX announced a semi-annual dividend of $0.2634 per share, reflecting a yield of 170.0%, with a dividend payout ratio of 28.49%.

American Century Companies Inc. lifted its holdings in RELX PLC (NYSE:RELX - Free Report) by 4.0% during the first quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 421,270 shares of the technology company's stock after buying an additional 16,170 shares during the quarter. American Century Companies Inc.'s holdings in RELX were worth $21,236,000 as of its most recent SEC filing.

Other hedge funds and other institutional investors have also recently modified their holdings of the company. Bleakley Financial Group LLC lifted its stake in shares of RELX by 1.5% in the 1st quarter. Bleakley Financial Group LLC now owns 14,147 shares of the technology company's stock worth $713,000 after purchasing an additional 207 shares during the period. Cynosure Group LLC increased its holdings in RELX by 3.5% in the 1st quarter. Cynosure Group LLC now owns 6,951 shares of the technology company's stock worth $350,000 after acquiring an additional 236 shares in the last quarter. Bridgewater Advisors Inc. increased its holdings in RELX by 2.1% in the 1st quarter. Bridgewater Advisors Inc. now owns 11,463 shares of the technology company's stock worth $617,000 after acquiring an additional 238 shares in the last quarter. Kovitz Investment Group Partners LLC increased its holdings in RELX by 3.4% in the 4th quarter. Kovitz Investment Group Partners LLC now owns 8,159 shares of the technology company's stock worth $371,000 after acquiring an additional 267 shares in the last quarter. Finally, Ascent Group LLC grew its holdings in RELX by 2.0% during the 4th quarter. Ascent Group LLC now owns 14,024 shares of the technology company's stock valued at $637,000 after buying an additional 277 shares in the last quarter. 15.02% of the stock is owned by hedge funds and other institutional investors.

Wall Street Analysts Forecast Growth

Separately, Wall Street Zen raised shares of RELX from a "hold" rating to a "buy" rating in a report on Saturday, July 26th. One analyst has rated the stock with a Strong Buy rating and four have assigned a Buy rating to the company's stock. According to data from MarketBeat, RELX has an average rating of "Buy".

RELX Price Performance

Shares of RELX stock traded down $0.32 on Friday, reaching $46.64. The company's stock had a trading volume of 1,853,527 shares, compared to its average volume of 1,586,397. The stock's fifty day simple moving average is $51.18 and its 200-day simple moving average is $51.38. RELX PLC has a 1 year low of $44.19 and a 1 year high of $56.33. The company has a current ratio of 0.47, a quick ratio of 0.42 and a debt-to-equity ratio of 2.55. The company has a market capitalization of $85.56 billion, a price-to-earnings ratio of 25.08, a price-to-earnings-growth ratio of 3.06 and a beta of 0.88.

RELX Cuts Dividend

The business also recently declared a semi-annual dividend, which will be paid on Tuesday, September 16th. Investors of record on Friday, August 8th will be given a $0.2634 dividend. The ex-dividend date is Friday, August 8th. This represents a yield of 170.0%. RELX's dividend payout ratio (DPR) is currently 28.49%.

RELX Profile

RELX Plc engages in provision of information and analytics solutions for professional and business customers across industries. It operates through the following business segments: Scientific, Technical & Medical; Risk & Business Analytics; Legal; and Exhibitions. The Scientific, Technical & Medical segment is a global information analytics business that helps institutions and professionals advance healthcare, open science, and improve performance for the benefit of humanity.